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Growing evidence demonstrates a continuous interaction between the immune system
and the skeletal muscle in inflammatory diseases of different pathogenetic origins, in
dystrophic conditions such as Duchenne Muscular Dystrophy as well as during normal
muscle regeneration. Although one component of the innate immunity, the macrophage,
has been extensively studied both in disease conditions and during cell or gene therapy
strategies aiming at restoring muscular functions, much less is known about dendritic
cells and their primary immunological targets, the T lymphocytes. This review will focus
on the dendritic cells and T lymphocytes (including effector and regulatory T-cells),
emphasizing the potential cross talk between these cell types and their influence on
the structure and function of skeletal muscle.
Keywords: myoblasts, macrophages, dendritic cells, effector T cells, regulatory T cells, polymyositis, Duchenne
muscular dystrophy
INTRODUCTION
The Interactions between the immune system and the skeletal muscle in different pathological
conditions such as inflammatory myopathies and muscular dystrophies represent a growing field of
investigation. Although the macrophage, one important component of innate immunity has been
extensively studied in different aspects of muscle regeneration, as well as adjuvants for cell or gene
therapy (Chazaud, 2020), much less in known about DC and its partner, the T cell.
During muscle repair macrophages were shown to acquire first a pro-inflammatory and
then an anti-inflammatory/regulatory profile, crucial for the maintenance and resolution of the
inflammatory process.
It is also known that during muscle repair, the differentiation of muscle progenitors into mature
muscle fibers involves a complex orchestration of different cell-cell and cell-matrix interactions as
well as interaction with many soluble molecules secreted by these different components present
within the regenerating muscle environment. Curiously, many of these mediators are molecules
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shared with the immune system (Tacke et al., 2009; Costamagna
et al., 2015; Sharma and Rudra, 2018). In fact, the cytokines
produced by cells of the immune system are not immune-
exclusive and many of them are essential for the homeostasis
of different tissues. Healing processes in general, use immune
mediators as messengers able to reorganize the tissue back into
a homeostatic steady state (Tacke et al., 2009; Costamagna et al.,
2015; Sharma and Rudra, 2018). However, the end point of the
healing process is not always favorable, and fibrosis may occur,
precluding healthy tissue from re-emerging. The differences
in the possible outcome, healthy vs. fibrotic tissue is strongly
dependent upon the correct spatial and temporal secretion of
these cytokines.
In healthy muscle, innate immune cells, mostly macrophages,
sit between the fibers, in the epimysium and perimysium. These
macrophages can be viewed as scavengers for debris, but also
as helpers, contributing to muscle formation/regeneration and
homeostasis (Lichtman et al., 2016; Zhang et al., 2017; Smigiel
and Parks, 2018). When any kind of injury hits a tissue, including
muscle, neutrophils are the first cells to migrate in, attracted
by chemokines, particularly IL-8, produced by the lesioned
endothelium (Perobelli et al., 2015; Silva-Barbosa et al., 2015;
Ley et al., 2018).
Very early after injury, resident macrophages and incoming
neutrophils are activated by a number of inflammatory stimuli
including Danger Associated Molecular Patterns (DAMPs) from
pathogens or mammalian cells themselves. DAMPs can trigger a
competent immune response (Matzinger, 1994; Matzinger, 2002)
after binding to the cognate receptors, Pathogen Recognition
Receptors (PRR) present on innate immune cells and on
various other cell types (Medzhitov et al., 1997; Medzhitov
and Janeway, 2002). The prototypical PRRs are the very
conserved family of Toll Like Receptors (TLR),a transmembrane
protein first known to regulate caudo-ventral orientation
of drosophila embryogenesis. Interestingly, when the TOLL
molecule is disrupted, it causes a morphological defect, but
more importantly, the flies die of fungal infection indicating
that TOLL is also involved in immunity (Lemaitre et al.,
1996). The major cell types expressing TLRs are the antigen
presenting cells: dendritic cells, macrophages and activated
B cells. Yet, other cells of the immune system and others,
including muscle, also carry them (Trinchieri and Sher, 2007;
Tournadre et al., 2010). More than ten different types of
TLRs have been described in mammals, recognizing molecules
characteristic of different pathogens or of internal damage. The
intracellular or cytoplasmic domain is conserved between TLRs
and interleukin-1 family of receptors (IL-1R) and as consequence
of activation, these receptors elicit a very potent inflammatory
reaction in general (Lemaitre et al., 1996; Medzhitov et al., 1997;
Medzhitov and Janeway, 2002).
In the case of an injured muscle, DAMPs derived from
the necrotic fiber and endothelial cells, and include Histidyl-
tRNA synthetase (HRS), High Mobility Group1 Binding protein
(HMGB1) and extracellular ATP. The HMGB1 protein, for
example, binds to its specific PRR, TLR4 (Sciorati et al.,
2016). Macrophages and dendritic cells, which both express
TLR4, are activated in such a way that they, not only
produce a number of proinflammatory cytokines (TNF-α, IL-
1, IFN-α, IFN-β), but also activate oxidative stress and nitric
oxide production, becoming competent antigen presenting
cells (Mogensen, 2009; Kawai and Akira, 2010; Cheng et al.,
2015; Liu and Cao, 2016). This means that if they meet T
lymphocytes, which can recognize the antigen on their surface
complexed to MHC molecules, the T cells will become activated.
As we will describe in this review, T lymphocytes together
with macrophages and DCs, are all found in inflammatory
muscle tissue, inflammatory myopathies such as myositis and
genetically inherited degenerative diseases of the skeletal muscle,
such as Duchenne muscular dystrophy (DMD) (Deyhle and
Hyldahl, 2018; Sass et al., 2018). We will provide evidence
that connects macrophages, DCs, T effector and T regulatory
cells and their secreted molecules. The discussion includes,
not only a description of those interactions, which are
mediated by the major histocompatibility complex (MHC)
and the T-cell receptor, but also cell-cell and cell-matrix
interactions, in a molecular context of self-within-self recognition
(de Sousa et al., 1991).
Macrophages: Role in Muscle
Regeneration
Macrophages are professional phagocytic cells, since they have
a high capacity to eliminate dead and apoptotic cells, cell
debris as well as a large number of pathogens. In addition,
they produce Reactive Oxygen Species (ROS), secrete soluble
factors such as cytokines and chemokines; and present antigens
to T lymphocytes. Moreover, macrophages participate in the
maintenance of tissue homeostasis and develop specialized
functions in a tissue dependent manner (Medzhitov, 2010; Varol
et al., 2015). These cells have a remarkable plasticity to adapt
to the milieu they are in. Accordingly, they can acquire a
pro-inflammatory or an anti-inflammatory/regulatory profile,
crucial for the maintenance and resolution of any inflammatory
process. In short, inflammatory components such as LPS and
cytokines like IL-12, IFN-γ, and TNF-α polarize monocytes
and macrophages into a pro-inflammatory population (also
known as M1 or classically activated macrophages). Conversely,
immunocomplexes, glucocorticoids, and cytokines such as IL-4,
IL-13, and IL-10 can induce subpopulation of anti-inflammatory
macrophages (known as M2, alternatively activated or regulatory
macrophages) (Italiani and Boraschi, 2014; Murray et al., 2014;
Vannella and Wynn, 2017; Jurberg et al., 2018).
As previously described, muscle repair is characterized by
inflammation (Tidball, 1995; Saclier et al., 2013). It has been
shown that pro-inflammatory macrophages co-localize with
proliferating myoblasts whereas macrophages expressing anti-
inflammatory markers (appearing concomitantly during muscle
regeneration) are preferentially associated with myogenin-
positive differentiated myoblasts (Lepper et al., 2011). Although
Pax7+ satellite cells are the only muscle stem cell responsible
for muscle regeneration (Warren et al., 2004; Murphy et al.,
2011), efficient muscle regeneration has been shown to depend
on signaling from other cell types, in particular macrophages. For
example, Ly6C+CCR2+ monocytes differentiate into different
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macrophages that directly support myogenesis, protect muscle
precursor cells from death, and stimulate myoblast proliferation,
differentiation, and fusion. Moreover, strategies that prevent the
arrival of monocytes into the skeletal muscle after tissue injury
result in impaired tissue repair (Cantini et al., 1994; Warren
et al., 2005; Summan et al., 2006; Arnold et al., 2007; Contreras-
Shannon et al., 2007; Martinez et al., 2010).
It has also been shown that co-cultures of macrophages
with myoblasts or macrophage-derived conditioned medium,
stimulate myoblast proliferation and delay their differentiation
(Johnson and Allen, 1990; Merly et al., 1999; Arnold et al., 2007;
Bencze et al., 2012). Furthermore, several pro-inflammatory
mediators, including TNF-α, IL-1β, IL-6, HGF, and IGF-I,
have been shown to promote myoblast proliferation (Sheehan
and Allen, 1999; Li, 2003; Zhang et al., 2013; González
et al., 2017; Chaweewannakorn et al., 2018). In particular,
HGF has been shown to enhance the migration of human
myoblast in vitro. This effect is potentiated by the presence
of extracellular matrix (ECM) proteins, with the involvement
of matrix metalloproteinases and the MAPK/ERK pathways
(Zhang et al., 2013). Interestingly the direct contact between
macrophages and myogenic cells protects myoblasts and
myotubes from cell death; this cell-cell contact being mediated
by cell adhesion interactions, including VCAM-1/VLA-4,
ICAM-1/LFA-1, and CX3CL1/CX3CR1 (Sonnet et al., 2006;
Lesault et al., 2012).
Overall, these data highlight the importance of macrophages
as myoblast supporting cells in the regeneration processes
(Chazaud et al., 2003; Briggs and Morgan, 2013).
Dendritic Cells and Muscle Inflammation
Dendritic cells (DCs) are at the interface between innate and
adaptive immunity. They are professional antigen-presenting
cells (APCs); being known as sentinels of the immune system.
They are resident components in non-lymphoid and lymphoid
tissues where they take up antigens, migrate into draining lymph
nodes, and trigger antigen-specific T and B cell responses (Padilla
and Reed, 2008; Hubert et al., 2019). Upon maturation, DCs up-
regulate co-stimulatory molecules and MHC Class II molecules
(HLA-DR) and secrete a variety of cytokines. Depending on
the tissue, the pathogen and the microenvironment, DCs
promote a specific and adequate immune response toward
Th1, interferon-γ (IFN-γ) secreting T lymphocytes, or other
T cell phenotypes like Th2, Th17, or even Treg lymphocytes.
Moreover, DCs play a crucial role in activating CD4+ and
CD8+ T cells, B lymphocytes (toward autoantibody production),
as well as providing different patterns of cytokine secretion
depending on the environment and stimulus they receive
(Hubert et al., 2019).
Using a murine model of muscle regeneration, it was
demonstrated that MHCII+ DCs and macrophages are present
within uninjured muscle, and after a transverse crush injury
in both anterior tibialis muscle, those cells increased and
remained high until day 6 (Pimorady-Esfahani et al., 1997). This
data is in agreement with another study, also in a myoinjury
model induced by injection of notexin into the anterior tibialis
and paravertebral muscle in mice. The authors showed that
after injury, the resident macrophages recruit neutrophils and
monocytes from the blood, which are progressively substituted
by inflammatory DC’s in the regenerating muscle (Brigitte
et al., 2010). Both macrophages and inflammatory DCs are
important in the response to muscle injury by recognition of
self-molecules (for example HMGB-1, SAA1, HSP, DNA, RNA)
released from damage cells through TLRs (TLR2/4 and TLR7/8),
thus triggering inflammation and tissue repair. However, in
dystrophies and myositis, the overwhelming release of cytokine
and over-active TLRs can lead to chronic and destructive
inflammation (De Paepe, 2020). As such, DCs can be placed
as relevant innate immune cells in the context of skeletal
muscle inflammation.
Despite the suggested role in a regeneration model, where
macrophages seem to have a more relevant and understood
role, DCs seems to have a greater participation in Idiopathic
Inflammatory Myositis (IIMS).
Idiopathic inflammatory myositis (IIMs) corresponds to a
heterogeneous family of diseases with a chronic or subacute
onset, involving immune cells and the injured tissue. More
recently, IIMs have been divided into four more clearly
defined clinical entities, namely dermatomyositis, inclusion body
myositis, immune-mediated necrotizing myopathy, and anti-
synthetase syndrome (Mariampillai et al., 2018). Over the past
years, many studies have tried to characterize the role of the
immune cells in IIMs (Tripoli et al., 2020). The evidence
for IIMs being an immune-mediated disease comes from the
presence of cellular infiltrates within the muscle biopsies, T
cell-mediated myocytotoxicity, autoantibodies in the peripheral
blood, and association with MHC class I overexpression (Syed
and Tournadre, 2015). IIMs are characterized by high levels of
circulating cytokines and chemokines, as well as by inflammatory
cellular infiltrates, including macrophages, DCs, CD8+ T cells
(predominantly affecting the endomysium in polymyositis) and
CD4+ T cells, which affect the perimysium in dermatomyositis
(Wiendl et al., 2005; Huang et al., 2018). Although the
involvement of DCs has been reported in IIMs (Greenberg, 2007;
Greenberg et al., 2007; Wirsdörfer et al., 2016; Hubert et al., 2019),
their exact role has not yet been defined.
Two different types of dendritic cells have been described in
the muscle infiltrates of IIM patients, with a predominance of
plasmocytoid DCs in dermatomyositis, and monocyte-derived
DCs in polymyositis and inclusion body myositis (Pimorady-
Esfahani et al., 1997; Wienke et al., 2018).
Interestingly, we have observed that human LPS-activated
monocyte derived DCs tightly interact with human myoblasts
and myotubes. This interaction seems to trigger myoblast
proliferation, migration, and cytokine release and to impair
myotube differentiation, thus suggesting that activated DCs
inhibit myotube formation and muscle regeneration. A similar
effect was observed when myoblasts and myotubes were
incubated with TNF-α, IFN-γ, and, TGF-β, suggesting a role of
circulating cytokines, in addition to the requirement for cell-cell
contact. Moreover, co-injection of human myoblasts and DCs
into freeze-injured tibialis anterior muscle of immunodeficient
mice enhanced human myoblast migration, although the absolute
number of human muscle fibers was unchanged (Ladislau et al.,
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2018), similar to what had been shown for macrophages (Bencze
et al., 2012). Similarly, increased numbers of activated DCs are
seen in inflamed muscle (Pimorady-Esfahani et al., 1997; Padilla
and Reed, 2008; Tournadre and Miossec, 2008) suggesting that
DCs may also present antigens to T cells at the site of the lesion
during myositis, in addition to the classic antigen-presentation
in the draining lymph nodes (Hughes et al., 2016). This could be
the trigger for autoantibodies production in some types of IIMs.
Interesting, myoblasts and muscle fibers from inflammatory
myopathies do express molecules typically expressed by APC
and/or T cells, namely ICAM-1, HLA-DR, HLA-ABC, CTLA-
4, CD28, BB-1, and B7-H1 increasing the chances of having
a positive loop on immune activation within the muscle, with
modulation of T cell activation and its fate.
The direct participation of DCs in the pathophysiology of
inflammatory myopathies was provided in a murine model
of polymyositis in C57BL/6 mice, consisting of the transfer
of bone marrow-derived dendritic cells (BMDC) pulsed with
a skeletal muscle specific antigen (the HILIYSDV peptide,
derived from skeletal muscle C protein fragment). Seven days
after immunization, the animals presented muscle lesions,
induced by DCs, like the features observed in polymyositis.
Importantly, such injury was mediated by CD8+ T cells
since anti-CD8 (but not by anti-CD4) depleting antibodies
suppressed disease progression. (Kohyama and Matsumoto,
1999; Okiyama et al., 2014, 2015).
Studies of DCs in Duchenne muscular dystrophy are much
scarcer than those reported for myositis. However, some data
point to an important role of DCs, since TLR7 expressed on
DCs binds to RNA and triggers cytokine production, enhancing
the inflammation/degeneration/regeneration cycle. Among the
cytokines released, the transforming growth factor (TGF)-β
seems to be strongly induced in symptomatic patients, which
would explain the participation of DCs, and their consequent
interactions with T cells, keeping a positive feedback loop
toward the maintenance of a fibrotic and dysfunctional muscle
(Mbongue et al., 2014; Rosenberg et al., 2015).
Lastly, it is worth mentioning that the research about DCs
during regeneration, myositis and DMD is complicated due to the
small number of these cells in the muscle and that their presence
probably occurs at the beginning of the disease development.
Since patients generally arrive at the hospital once the disease is
already established, possibly the role of DC is not relevant at this
late time point.
T Cells in Idiopathic Inflammatory
Myopathies and Duchenne Muscular
Dystrophy
As mentioned earlier, immune cellular infiltrates including T
cells, DCs and macrophages are present in muscle biopsies
of inflammatory muscle diseases (Syed and Tournadre, 2015).
In this context, with regard to idiopathic inflammatory
myositis, an important participation of CD4+ Th1, and
Th17 cells, B lymphocytes, CD8+ T lymphocytes and type I
interferon has been reported (Tournadre and Miossec, 2012;
Moran and Mastaglia, 2014; Reed et al., 2015; Crowson
et al., 2019; Patwardhan and Spencer, 2019). The mechanisms
involved in the pathophysiology of the different IIMs seem
to differ. While CD8+ T cells seem to be important in
the pathogenesis of polymyositis and inclusion body myositis,
CD4+ T cells and B cells play a predominant role in
the pathogenesis of dermatomyositis (Rosenberg et al., 2015;
Syed and Tournadre, 2015).
Also, the relevance of cytokines in the skeletal muscle
lesions seems to be vary according to the IIMs. While type I
interferon has been detected in the muscle fibers of patients
with dermatomyositis, as well as in plasmacytoid dendritic
cells and in the endothelial cells in capillaries, overexpression
of IFN-γ induced genes has been associated with inclusion
body myositis (Reed et al., 2015; Crowson et al., 2019;
Patwardhan and Spencer, 2019).
In the endomysium of patients with inclusion body
myositis, dermatomyositis and polymyositis, the presence of T
lymphocytes expressing restricted TCR families, in particular
Vα2 and Vβ3, suggests that clones capable of recognizing
autoantigens participate in the pathophysiology of these diseases
(Lindberg et al., 1994). Similarly, in patients with polymyositis,
it was observed that endomysial CD8+ T cells surround and
invade muscle fibers that express MHC class I antigens, with
the consequent release of cytotoxic molecules, tissue destruction
and release of autoantigens (Hohlfeld and Engel, 1991; Lindberg
et al., 1994; Kohyama and Matsumoto, 1999; Levine et al., 2007;
Tournadre and Miossec, 2012; Mbongue et al., 2014; Moran
and Mastaglia, 2014; Reed et al., 2015; Rosenberg et al., 2015;
Syed and Tournadre, 2015; Patwardhan and Spencer, 2019;
Crowson et al., 2019). Moreover, numerous CD4+ and CD8+
T lymphocytes with the phenotype of terminally differentiated
cells have been observed in polymyositis and dermatomyositis
patients (Crowson et al., 2019). Such cells revealed a cytotoxic
capacity, expression of receptors related to NK cells being potent
IFN-γ and TNF producers (Fasth et al., 2009). Moreover, in vitro
studies have shown that such lymphocyte subpopulations are
cytotoxic to myotubes (Loell et al., 2011).
Despite previous studies showing increased frequency of
highly differentiated CD8+ T cell effector memory and terminally
differentiated effector cells in patients with dermatomyositis
and polymyositis, a recent study evaluating patients with
various inflammatory myopathies, as well as patients with
immune-mediated necrotizing myopathy, reported the presence
of such a subpopulation only in patients with inclusion body
myositis (IBM) (Greenberg et al., 2019), which could justify the
resistance of these patients to treatment with corticosteroids,
since terminally differentiated effector cells seems to be resistant
to corticotherapy (Benveniste and Allenbach, 2019).
In Inclusion Body myositis, it has been proposed that
CD8+ terminally differentiated memory effector (TEMRA)
T cells are involved in the pathophysiology of the disease
through mechanisms involving cytotoxic enzymes (perforin
and granzyme) as well as being mediated by IFN-γ, leading
to an increase in the expression of HLA class I molecules,
endoplasmic reticulum stress and proteasome dysfunction, with
a consequent induction of rimmed vacuole formation and
degenerative features (Arahata and Engel, 1984).
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More recently, some studies focusing on polymyositis and
dermatomyositis (not including inclusion body myositis) have
suggested the participation of Th17 cells and the cytokines IL-
17, IL-22, and IL-6 in the pathophysiology of IIMs. Moreover,
IL-17A has been reported in the muscle tissue of patients
with IIMs and in vitro studies suggest that IL-17A could play
a role in the pathophysiology through mechanisms involving
chemokine upregulation, increased inflammation and decreased
cell migration and myogenic differentiation. Although such
findings may point to new therapeutic perspectives, some results
remain controversial and further work is still needed (Tournadre
and Miossec, 2012; Moran and Mastaglia, 2014; Syed and
Tournadre, 2015).
Pioneer studies in DMD patients revealed that the
intramuscular inflammatory infiltrate is mainly composed
by T lymphocytes (especially CD8+ T cells) and macrophages
(Arahata and Engel, 1984). Since then, several studies have been
carried out to clarify the participation of the immune system
in the pathophysiology of this disease. In this respect, it has
been proposed that the absence of dystrophin and subsequent
muscle cell damage, would result in the release of intramuscular
antigens that could be specifically recognized by cells of the
immune system (Spencer and Tidball, 2001). In such a context,
it has also been observed that T lymphocytes present in the
muscle tissue of patients with DMD predominantly express
TCR Vβ2, and that this is not a characteristic shared by diseases
involving inflammation of muscle tissue, since it was not
detected in patients with polymyositis (Arahata and Engel,
1984). In addition, most patients with DMD have a conserved
sequence of four amino acids in the CDR3 region of the TCR
Vβ2, suggesting that the T cells present in the inflammatory
infiltrate may recognize a specific muscle antigen (Mantegazza
et al., 1993; Gussoni et al., 1994). Moreover, it has also been
demonstrated that all DMD muscle fibers that were invaded by
CD8+ T cells expressed MHC class I molecules on their surfaces
(Emslie-Smith et al., 1989). Once activated, cytotoxic CD8+ T
lymphocytes could then migrate and recognize specific peptides
on the surface of muscle fibers triggering the release of perforin,
granzyme and TNF-α, resulting in tissue damage.
In a cohort of 75 DMD patients, we have observed
that increased percentages of circulating CD4+CD49d+ and
CD8+CD49d+ T lymphocytes were correlated with a more
rapid progression of the disease. Functionally, T cells from the
more severely affected patients exhibited higher trans-endothelial
and fibronectin-driven migratory responses when compared to
healthy individuals (Pinto-Mariz et al., 2015).
We also observed a higher expression of fibronectin in
the muscle of DMD patients, especially those with a worse
prognosis, that is, those who lost the ability to walk before the
age of ten. More importantly, both CD49+CD4+CD3+ and
CD49+CD8+CD3+ were detected within the fibronectin-
containing network of the injured muscle (Figure 1).
Considering the haptotactic role of fibronectin on T lymphocytes
(further enhanced upon activation), the increased production
of this protein in muscle tissue of dystrophic patients could
enhance the recruitment of more activated T cells toward the
lesion. In fact, CD49d+ T cell subsets were found in muscular
FIGURE 1 | Presence of infiltrating CD8+ T lymphocytes within the muscle of
a patient being Duchenne muscular dystrophy: possible inhibition by VLA-4
inhibitors. (A,B) reveal CD49d+HLA-DR+CD8+ T cells within the muscular
tissue. The biopsies were performed at the onset of the disease. Patients
were split according to loss of ambulation before or after 10 years of age.
Data were calculated by counting labeled cells by in situ immunofluorescence
made on frozen sections of muscle biopsies for simultaneous detection of
CD8, HLA-DR, and CD49d. (A) depicts the numbers of CD8+ cells per
inflammatory field, whereas (B) reveals that the relative numbers of
CD49d+HLA-DR+CD8+ T were significantly higher in the muscles from
children who lost ambulation before the age of 10 years (slightly modified from
Pinto-Mariz et al., 2015). (C) illustrates the notion that CD49d inhibitors can
block the VLA-4 activity on the transendothelial migration of T lymphocytes
(Chazaud, 2020), as well as upon the intramuscular migration of the cells
through a fibronectin-containing extracellular network, depicted as pink
molecules in the scheme (Sharma and Rudra, 2018). Finally, adhesion of
CD49dhigh T cells to myoblasts as well as myotubes can also be abrogated by
an anti-CD49d monoclonal antibody (Tacke et al., 2009), by consequence
inhibiting muscle cell apoptosis. * indicates significant difference with
p < 0.05.
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inflammatory infiltrates, and a higher number of activated
CD49d+HLA-DR+CD8+ T lymphocytes in the muscle of
patients who had a rapid disease progression (Figure 1).
Moreover, a higher adhesion of cells obtained from DMD
patients to myotubes were observed when compared to healthy
controls (Pinto-Mariz et al., 2015).
The importance of CD49dhigh T lymphocytes in the
pathogenesis of the disease has also been observed in the most
relevant animal model for this human disease, namely the Golden
Retriever muscular dystrophy dog (GRMD). An elevation in the
number of circulating CD4+CD49dhigh T cells at early stages
of the disease seems to be highly predictive for the loss of
ambulation before 6 months of age (Barthélémy et al., 2014).
The same result was not observed with CD8+CD49dhigh T cells,
suggesting that some mechanisms in GRMD may be different
from those involved in DMD human patients. In any case, this is
an important finding for stratifying these animals for pre-clinical
therapeutic studies.
With regard specifically to muscle tissue, an increase in the
gene expression of interferon-γ, TGF-β and chemokines, such
as CCL14, CCL2, CXCL-12, and CXCL-14 in patients with
DMD has been shown (Evans et al., 2009). Considering that
extracellular matrix (ECM) elements can interact directly with
immune cells also functioning as a substrate for binding soluble
factors such as cytokines and chemokines, we could suggest
that the combined action between the increase in fibronectin
expression, associated with the rise in some chemokines and
cytokines could lead to increased recruitment of inflammatory
cells to this area. This would result in a perpetual cycle of
inflammatory infiltration and deposition of ECM elements, these
events being more prominent in the most severe patients.
Considering the studies performed in DMD patients, it is
conceivable that the muscle damage initially caused by the
absence of dystrophin could result in exposure of antigens on
the surface of muscle fibers. Activated T lymphocytes with high
expression of CD49d on the surface could migrate to muscle
tissue directed by a chemotactic/haptotactic gradient. Moreover,
we demonstrated that CD49dhi T cell subsets obtained from
DMD patients have a higher in vitro migration capacity across
endothelial layers and through fibronectin, when compared to
CD49dlow T subpopulations (Pinto-Mariz et al., 2015). Once
in the tissue, CD8+CD49dhi T lymphocytes could recognize
antigens on the surface of the fibers causing their destruction.
The higher relative numbers of CD49dhi T cell subsets in
the blood of more severe patients, associated with an elevated
migratory responsiveness, together with a higher expression
of fibronectin and activated CD8+ T cells in the muscle,
could explain in part the early loss of gait observed in this
group of patients.
Overall, effector T cells are important in DMD
pathophysiology and evolution with a special role for the
CD49dhigh T cell subpopulations. In this context, CD49dhigh cells
can be used as a prognostic marker of disease progression and
CD49d inhibitors can be envisioned as a therapeutic approach to
decrease inflammation-mediated tissue damage (see Figure 1),
with consequent amelioration in the quality of life in DMD
patients. As a hope for treating DMD, a clinical trial using siRNA
to inhibit CD49d expression in T cells in DMD patients between
10 and 18 years old with loss of deambulation is ongoing and
already in phase II1.
Immune Cross Talk in Skeletal Muscle:
The Role of TREG CELLS
As stated above he crosstalk between T cells and
macrophages/dendritic cells is essential for immune activation
and its maintenance. Although, when shifted to type 1/Th1
immune responses it has a damaging aspect, these same signals
are crucial for muscle regeneration, and development. However,
if the type 1 response (which includes M1 macrophages and
Th1 cells) is not resolved, muscle differentiation does not take
place and fibrosis is established (Zhang et al., 2014; Tidball, 2017;
Muire et al., 2020).
Fortunately, the immune response has an incredible plasticity
and an ongoing response, when healthy, stimulates its own
regulation and this is what happens in normal muscle
regeneration. Immediately after muscle damage, the type 1
response dominates the scene with the arrival of Th1 lymphocytes
and a stimulation of proinflammatory cells. In this phase,
proliferation of myoblast progenitors and initial differentiation
occurs. This response is crucial for the whole regenerative process
and depends on T cells. Genetic deletion of CD8α impairs M1
macrophage infiltration, through the absence of CCL2, leading to
a defective muscle regeneration (Zhang et al., 2014). These data
indicate the important role of chemokines secreted by CD8+ T
cells upon monocyte/macrophage attraction to the muscle.
Three to 5 days after the initial injury, there is a shift in the
response from a type 1 toward a type 2 (M2 macrophages and
Th2 cells)/Treg activity, favoring myoblast fusion and myofiber
formation (Riederer et al., 2012).
The signals responsible for this shift are not completely clear,
but it is evident that M2 macrophages, secreting TGF-β and IL-
10, are crucial for myoblast fusion and maturation (Horsley and
Pavlath, 2004). Also, other cells, such as eosinophils, migrate
to the lesion and through IL-4/IL-13 secretion modulate fibro-
adipogenic precursors (FAP) toward myoblast differentiation
supporting fibroblasts (Horsley and Pavlath, 2004; Heredia
et al., 2013). IL-4 is also known for its direct role on
myoblast fusion through IL-4R present on myoblast and nascent
myotubes. Interestingly, this cytokine can be secreted, not
only by type 2 immune cells, but also by the myoblasts
themselves and the nascent fibers, with a dependence on
different NFAT family molecules, similar to the biochemical
regulation of T cell differentiation and cytokine secretion
(Horsley and Pavlath, 2004).
In parallel to the type 2 response shift, regulatory T cells
(Treg) migrate to the lesion and dominate the T cell scenario
(Burzyn et al., 2013). Treg cells are CD4+ T lymphocytes,
characterized by the expression of the transcription factor FoxP3,
surface expression of CTLA-4, GITR (the glucocorticoid-induced
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They can be generated in the thymus during T cell ontogeny or
induced in the periphery of the immune system. These cells have
an inhibitory action over most immune cells (including other
T lymphocyte subpopulations, DCs, macrophages, B cells) and
their effector function depends on antigen recognition, enabling
secretion of cytokines, such as TGF-β and IL-10. Moreover,
inhibitory activity dependent on cell-to-cell contact, has been
reported in the absence of TGF-β or IL-10 (Thornton and
Shevach, 1998; Shevach, 2006; Ring et al., 2010; Zhang et al.,
2017), reinforcing the notion that various mechanisms underly
Treg effector function.
In human inclusion body myositis, it has been shown
that Tregs are present in small numbers within the muscle,
suggesting that the disease is associated with limited Treg
numbers, impacting on the suppression by regulatory
T cells over an ongoing inflammatory response (Prevel
et al., 2013; Allenbach et al., 2014). In contrast, in juvenile
dermatomyositis and DMD, Tregs seem to be increased
in the diseased muscle although they are less effective in
suppressing an immune response (Vercoulen et al., 2014;
Villalta et al., 2014). In line with these findings, a study using a
Toxoplasma gondii experimental model has shown that muscle
from animals infected with the parasite are rich in Treg cells, and
that Treg elimination allows M2 differentiation, with consequent
improvement in muscle homeostasis, thus suggesting that
during this chronic infectious stimulation Tregs gain a different
functional phenotype (Jin et al., 2017). This can be the result
of a chronic inflammatory environment where Tregs, under
chronic IFN-g stimulation may acquire a Th1/Treg phenotype,
contributing to inflammation and tissue damage. Together
these results show that evaluating only the numbers of Treg’s
is not sufficient to tell if they are functional or not in chronic
muscular diseases. Functional assays are therefore necessary to
clarify this issue.
The arrival and maintenance of Tregs in the muscle have
been shown to depend on at least two different mechanisms.
One of them is dependent on the ATP/P2X axis and was shown
in the mdx mouse model of DMD. In this study the authors
FIGURE 2 | Temporal regulation of the innate and adaptive immune response in muscle injury and healing. Immediately after aggression, muscle cells, as well as
fibro-adipogenic precursors (FAPs), produce IL-33. This cytokine induces expansion of the PAX7+ satellite cell pool, which themselves also produces IL-33. The
necrotic muscle cells release DAMPS, which will stimulate innate immune cells, including resident macrophages and dendritic cells toward a type 1 response
represented by the redish colored cells. This initial inflammatory mediator production is guided by cytokines and signals originated from the lesioned muscle. As a
result, the whole initial environment is embedded in type 1 cytokines and rapidly incoming cells as neutrophils contribute to the inflammation by several mechanisms.
Importantly, after being activated by DAMPs (up to 3 days) both cell types, macrophages and DC, become competent to activate incoming CD4 (Ths) and CD8 T
cells keeping, or deviating their function, to a Type 1, building a positive inflammatory loop (this T activation happens in the LN, regardless its possible activation
inside the lesioned muscle). Many of the inflammatory cytokines, like TNF-α, IL-1ß, and IL-6 stimulate myoblast progenitor proliferation. After neutrophils come in,
attracted by chemokines produced by the vascular endothelium, FAPs and muscle cells themselves, neutrophils are activated, perform their function and evolve to
apoptosis. Incoming CD8 cells, besides producing CCL2 which attracts monocytes, will also generate apoptotic bodies by killing damaged muscle cells.
Phagocytosis of apoptotic bodies (from neutrophils and muscle) guides macrophages and dendritic cells to a type 2, or type 2 like phenotype(c), contrary to
engulfment of necrotic bodies which carry DAMPs. This initial shift is crucial to deviate T cells to a Th2 phenotype. Type 2 responses are linked to IL-4 production
which is necessary for myoblast differentiation and fusion. TGF-ß and IL-10 also have roles in the myoblast differentiation and fusion. Interestingly, type one response
impairs muscle cell differentiation and maturation. As the healing response progress, together with the shift to type 2 immune response, SP2+ Tregs attracted by
IL-33, get more numerous and dominates the T cell scenario. Muscle Tregs not only shut down the ongoing immune response but also participate in the healing
process, characteristically respond to IL-33 (are ST2+ Tregs) producing AREG – a crucial cytokine to expand and maintain the number of satellite cells, in the
absence of which regeneration is impaired.
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blocked the ATP/P2× 7 interaction with periodate-oxidized ATP
and observed an increased number of Tregs within the injured
muscle. Importantly, in the absence of ATP/P2 × 7 signaling,
not only the Tregs did arrive in the lesion but muscle damage
was reduced, indicating that ATP blocks Treg arrival and in the
absence of Treg, muscle damage is more severe (Gazzerro et al.,
2015). Much more is known about the IL-33 mediated Treg
arrival and maintenance within the muscle. IL-33 is an alarmin
produced by FAPs and skeletal muscle stem cell which binds
to the interleukin-1 receptor-like 1 protein (also named ST2)
present on CD4+ T cells (including Tregs), macrophages and
FAPs. In fact, FAP-derived IL-33 is crucial for Treg accumulation
within the muscle, and consequently, muscle regeneration
(Castiglioni et al., 2015). Muscle T regs, characteristically express
ST2 and produce amphiregulin (AREG), a pleiotropic molecule
with diverse functions in tissue regeneration and immune
suppression (Burzyn et al., 2013; Jin et al., 2018). In the muscle,
AREG has been shown to be important for skeletal muscle stem
cell expansion in response to IL-33. In addition, muscle Tregs can
be modulated by IL-33 producing AREG (Burzyn et al., 2013).
Tregs are present in the injured muscle from the very first day,
peak between days 3 and 5, and remain in the infiltrate as the
majority of T cells until the resolution phase, by day 15). In
ageing mice, a deficient production of IL-33 has been shown to be
correlated with a diminished migration of Tregs into the muscle
whereas treatment with exogenous IL-33 restored the Treg
influx and improved muscle regeneration (Kuswanto et al., 2016;
Jin et al., 2018).
Regulatory T lymphocytes produce several other cytokines,
such as TGF-β and IL-10. Treatment with IL-10 or AREG, both
of which are muscle Treg-derived products has been shown to
improve muscle repair, as ascertained by an increase in satellite
cell and myoblast/myotube markers (Jin et al., 2018). These
results strongly suggest that the presence of Tregs contributes
to muscle repair.
As mentioned at the beginning of this section, T cells, no
matter whether they are CD4 or CD8, T helper or regulatory,
need to engage their antigen recognition receptor so that they
can signal to other cells. To address this question, Diane Mathis’s
laboratory showed an increased frequency of one TCR specificity
amongst various mouse strains, suggesting that there is an
antigen driven accumulation of Tregs in the muscle (Thornton
and Shevach, 1998). The same authors made a transgenic mouse
carrying this highly frequent TCR (named mTreg24 tg) and
showed that Treg accumulation was in fact antigen driven (Cho
et al., 2019). More importantly, this model allowed them to
study the kinetics of muscle Treg phenotype acquisition with
cell transfer experiments. After transfer of the muscle specific
T cells to a normal mouse, muscle Treg phenotype (ST2+) was
only observed within the muscle, while splenic Tregs, even being
specific for muscle antigens, showed the expected splenic Treg
signature, with no expression of ST2. Moreover, in the mdx model
for DMD, mTreg24 provides an accelerated rate of regeneration
when compared to polyclonal Treg cells (Cho et al., 2019). It
should be noted, however, that such muscle T reg specificity
has not yet been studied in humans (Vercoulen et al., 2014;
Villalta et al., 2014).
In summary it is very clear that Treg lymphocytes play an
important role in the injured/regenerating muscle. Not only
do they act as immune suppressors over other immune cells,
dampening the inflammatory type 1/Th1 response, but they
receive signals from macrophages, FAPs and skeletal muscle stem
cells, which in turn, seem to shape their modulatory phenotype
inside the muscle. In return, a number of cytokines are secreted
by Tregs, favoring muscle stem cell proliferation and progression
to myoblast differentiation and fusion in regenerating muscle
fibers, if the injury is not chronic. Yet, it should be pointed
out that the orchestration of all muscle Treg activities depend
on Treg specificity, the only way for T cells to interact long
enough with its target, in order to trigger a localized response
within the tissue.
CONCLUDING REMARKS
The data discussed above clearly demonstrate the complexity
of the cellular and molecular interactions between the skeletal
muscle and the immune system, particularly during muscle
inflammation. Such a complexity comprises distinct types
of interactions, including the production of soluble moieties
(cytokines, chemokines), cell-cell interactions mediated by
integrin-type ECM receptors, as well as the canonical TCR/MHC-
peptide interactions of T lymphocytes with other cells of
the immune system or, in certain conditions, with myoblasts
themselves. Overall, this complex scenario is schematically
depicted in Figure 2.
All these interactions take place independently of a given
pathogen-derived antigen, being thus a sort of self-within-self
recognition at distinct levels of specificity. Accordingly, we
think that it should be necessary to take into account all these
interaction levels and specificities, when designing cell or gene
therapy strategies for correcting genetic or acquired diseases of
the skeletal muscle.
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